Careers News Investors
Home Health Care Professionals Products

ALLEVYN LIFE Treatment Global

ALLEVYN◊ LIFE Foam Dressings

840x840-PX-ALLEVYN-LIFE-Treatment-Global.png

Rethink community wound care

  • Wound care accounts for 2-4% of total healthcare expenditure in Europe, costing a mean €6,000 to €10,000 per patient with chronic wounds each year9

  • Almost 70% of dressing changes are driven by schedules3

  • 50% of changes in the community are clinically unnecessary4

    • However, optimal dressing choice and avoidance of unnecessary dressing changes may help improve patient experience,10 enable undisturbed healing and reduce the risk of infection10 while alleviating pressures on nursing time.10

    Product feature

    Related technologies

    Customer information

    *Compared to previous dressings. Ambispective (retrospective and prospective) observational study. 1.66 ALLEVYN LIFE Dressings vs 3.14 previous dressings (including foams and gelling fibres); n=94; p<0.001). €11.45 ALLEVYN LIFE Dressings vs €27.70 previous dressings (including foams and gelling fibres); n=94; p<0.001).

    **Dressing retention is 1.92x longer; n=37. Cost and visit efficiencies demonstrated vs baseline when used with appropriate training, education, and promotion of practice change.

    Citations
    1. Milne J, Searle R, Styche T. The characteristics and impact of hard-to-heal wounds: results of a standardised survey. J Wound Care. 2020;29(5):282-288.
    2. Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016;13 Suppl 2:5-15
    3. Smith & Nephew Wound Management Clinical Report UKI-CP-PDTK-2013-DCF/RFC-1-5-14 May 2014. In-practice dressing change frequencies and reason for dressing change 2013 Community Practice Development Tool Kit (PDTK) survey data analysis
    4. Joy H, Bielby A, Searle R. A collaborative project to enhance efficiency through dressing change practice. J Wound Care. 2015 Jul;24(7):312, 314-7.
    5. Simon D, Bielby A. A structured collaborative approach to appraise the clinical performance of a new product. Wounds UK. 2014;10(3):80-87.
    6. Rossington A, Drysdale, K., and Winter, R.,.Clinical performance and positive impact on patient wellbeing of ALLEVYN Life. Wounds UK. 2013;9(4):91-95.
    7. Stephen-Haynes JB, A., and Searle, R., .The clinical performance of a silicone foam in an NHS community trust. Journal of Community Nursing. 2013;27(5):50-59.
    8. Tiscar-Gonzalez V, Rodriguez MJM, Rabadan Sainz C, et al. Clinical and economic impact of wound care using a polyurethane foam multi-layer dressing versus standard dressings on delayed healing ulcers. Adv Skin Wound Care. 2021;34(1):23–30
    9. International Best Practice Statement: Optimising patient involvement in wound management. Wounds International. 2016. Available at: https://www.woundsinternational.com/resources/details/international-best-practice-statementoptimising-patient-involvement-in-wound-management. Accessed Sep 2020
    10. Blackburn J, Stephenson J, Atkin L, Southern T, Ousey K. Exploring and understanding challenges in clinical practice: appropriate dressing wear time. Wounds UK. 2018;14(5):56-64.
    11. Smith+Nephew 2016.New ALLEVYN Life Gen2 wcl - Physical Testing. Internal Report. DS/15/025/R
    12. Smith+Nephew 2016.Wound Model Testing of New ALLEVYN Life Gen2 wcl Dressing using Horse Serum at a Flow Rate Modelling that of a Moderately Exuding Wound. DS/14/303/R
    13. Smith+Nephew 20 June 2016.A Randomised Cross-Over Clinical Evaluation to Compare Performance of ALLEVYN™ Life and Mepilex® Border Dressings on Patient Wellbeing-Related Endpoints. Internal Report. CE/047/ALF.
    14. Smith+Nephew February 2016 2016.Subjective comparison of masking ability of the New ALLEVYN LIFE versus Current ALLEVYN LIFE by Healthcare Professionals. Internal Report. DS/16/061/R.

    Title

    Text

    Explore